Abbott | Omacor | Health Care Professionals

Useful topics

find out more....

High triglycerides are considered an independent risk factor in people with diabetes^1-4

Triglyceride levels >2.3 mmol/l doubled the risk of CHD events, independently of other risk factors⁴

One-third of people with type 2 diabetes may have high triglycerides⁵

Triglycerides make diabetes more dangerous

Statins have a modest effect on triglycerides⁶

Statins effectively reduce LDL-C but have less effect on triglycerides,⁷ so treatment goals may not be reached with statins alone⁸

What is the threshold of high triglycerides?

1.7 mmol/l is defined as the threshold of hypertriglyceridaemia by the American Heart Association,⁹ the European Society of Cardiology/European Association for the Study of Diabetes,¹⁰ the UK Joint British Societies,⁶ and Diabetes UK¹¹

NICE CG87¹²

(despite optimised glycaemic control)

NICE CG87¹²

(patients with high CV risk)

International Diabetes Federation¹³

(after LDL-C optimisation)

AHA,⁹ ESC/EASD,¹⁰ JBS2,⁶ Diabetes UK¹¹

Omega-3 fatty acids offer efficacy beyond statins^8,14

Only Omacor is:

Highly purified

a pharmaceutical-grade preparation containing 90% omega-3 fatty acids

Clinically proven

supported by RCT data
the only omega-3 product licensed for use after MI and in hypertriglyceridaemia

Precisely formulated

delivers 840mg of EPA + DHA in every 1g capsule, which may improve compliance and reliability compared with OTC supplements¹⁶